Biosensors   

Is Biosensors a good buy?

drop to 0.50 lagi better.

 

On Friday, Biosensors re-test the resistance at $1.20 and closed at $1.20 with LOW volume of 2.11 million shares traded.

A doji star occurred (where a doji gaps above or below the previous candle).  This often signals a reversal with confirmation occurring on the next bar.

A long lower shadow occurred.  This is typically a bullish signal (particularly when it occurs near a low price level, at a support level, or when the security is oversold).

RSI & MACD are bullish as MACD lines about to perform a “golden cross”.

Important Resistance of Biosensors: $1.20

Immediate Support of Biosensors: $1.11

Currently prices are well below the 20/50/100/200 MA.

For the past 8 trading sessions    ............    READ MORE

 

 

Why see this as a trap? I see it as an opportunity.

Hope the price go lower to $0.88. The founder/chairman will be happy to buy back his shares instead of waiting to exercise an option at $1.50.

yiming2000      ( Date: 18-May-2012 22:33) Posted: Are you vested or just watching for an opening to get trapped like us? tiptop123      ( Date: 18-May-2012 15:09) Posted: Look like there are still some short positions not cover yet! Just wait and see....

 

Are you vested or just watching for an opening to get trapped like us?

tiptop123      ( Date: 18-May-2012 15:09) Posted: Look like there are still some short positions not cover yet! Just wait and see....

 

Look like there are still some short positions not cover yet!

Just wait and see....

 

so bio is the leader in selling down...lol

 

infancybird      ( Date: 18-May-2012 13:21) Posted: Just my view:- I can only say that I am quite relieve to note that the  big big continuous selling by insiders for the last two months plus has stopped since this Monday. No more price suppression is seen now. We are at a base price that suit the BB and the next move shall be up and not down.  Have only 12 more agonizing days to wait for ,hopefully,  start of flow of good News  . daylight28      ( Date: 18-May-2012 11:14) Posted: everything is red today.

 

STI  support level  ---2700  then 2610

before return bull run.

not to buy yet.

 

Just my view:-

I can only say that I am quite relieve to note that the  big big continuous selling by insiders for the last two months plus has stopped since this Monday. No more price suppression is seen now. We are at a base price that suit the BB and the next move shall be up and not down.  Have only 12 more agonizing days to wait for ,hopefully,  start of flow of good News  .

daylight28      ( Date: 18-May-2012 11:14) Posted: everything is red today.

 

Topdog22 - we are all kena trapped like you. Be our sifu and help us huat.

 

I hope you are right...I, too, have big long bet on this counter.

topdog22      ( Date: 16-May-2012 08:05) Posted: I agree the stock movements are " funny" BUT I beleive there will be at least a $30M upside surprise on net income as rthe company will release a tax reserve plus have stronger royalties from Terumo.  I think based on how fast it went down there will be an corresponding movement in the oposite direction later this month and it will hit overshoot the target pricve making new hi's of 1.80.  Let's watch and see.  P.S. BTW I have big long bet on BIG!

 

everything is red today.

 

bioss macd convergence?

 

This share always have good news but bad timing...

 

TERUMO JAPAN -Q1 2012 Results out

Overall revenue and sales down, but Cardio vascular sales up 14%.

Positive for Biosensors coming results

 

Axxess™ Self-Expanding Bifurcation DES

Shown to be Safe and Effective up to Four Years

Singapore, 18 May 2012 –

DIVERGE, a prospective, single-arm, multi-center study of 302 patients with de novo bifurcation lesions across 14 sites in Europe, Australia and New Zealand, is the largest study conducted to date with a DES specifically designed for treating coronary bifurcation lesions. Following implantation of Axxess, the side branch treatments were left at the operators’ discretion. Additional conventional sirolimus-eluting stents (SES) were placed in 21.7% of the distal parent and/or side branch vessels. In 64.7% of the cases both branches were treated with an additional SES.

At four years post-procedure, 96.7% of patients originally enrolled in the study (292) were available for follow-up. The cumulative rate of MACE was 18.5%. The occurrences of the individual components were 5.1% for cardiac death, 7.9% for myocardial infarction and 10.6% for ischemia-driven TLR.

There were only three cases (1.0%) of Academic Research Consortium (ARC)-defined definite VLST, all of which involved at least one SES: just one of these cases also involved Axxess. No VLST events were observed in Axxess patients between years three and four of the study.

" These long-term results from DIVERGE are important because of the frequent presentation of bifurcation lesions in our daily clinical practice," commented Principal Investigator Dr. Stefan Verheye, Antwerp Cardiovascular Institute, Belgium. " These types of lesions are associated with higher complication and restenosis rates compared to conventional lesions. The four-year results confirm the earlier results already presented, and strengthen the evidence that the Axxess stent is a safe and effective alternative for patients with certain bifurcation lesions." Page New long-term data from the DIVERGE study, presented yesterday at EuroPCR 2012 by Dr. John Ormiston, showed that the use of the Axxess™ drug-eluting stent (DES) for the treatment of complex coronary bifurcation lesions resulted in low levels of both MACE (a composite of cardiac death, MI and ischemia-driven TLR) and VLST (Very Late Stent Thrombosis) over a four-year period. Axxess™ is a self-expanding bifurcation stent which releases Biolimus A9™ from an abluminal biodegradable polymer coating. 2 of 3

The Axxess bifurcation DES consists of a conical-shaped self-expanding nitinol (nickel/titanium) stent platform, specifically designed to conform to the shape of the bifurcation anatomy. It has been tailored to reconstruct the bifurcation without creating a false carina (the ridge where the two vessels join), lowering the risk of uncovered struts at the flow divider. The stent is coated with a biodegradable poly-lactic acid (PLA) polymer that releases Biolimus A9™ (BA9™), an anti-restenotic drug designed by Biosensors specifically for use with DES. Both BA9 and the biodegradable polymer are vital components of the BioMatrix™ DES family, which has more published data to support its safety and efficacy than any other biodegradable polymer DES.

Biosensors received CE Mark approval for Axxess in April 2011, supported by the positive nine-month results from the DIVERGE trial, which were published in the Journal of the American College of Cardiology (JACC) in March 2009. These demonstrated low overall rates of MACE (7.6%), restenosis (0.7%) and late stent thrombosis (0.3%) in patients treated with Axxess.

Axxess is now available in most major markets worldwide.

 

How come my smiley is not like yours but always has a border  around it like this.   

tiptop123      ( Date: 17-May-2012 20:47) Posted: This counter no more meat! All the shortists run road lao.... Can see a long leg DOJI on the weekly chart now. Good entry price for long term investor.

 

i shorted this heavily when it was at 1.43 & 1.31. 

nv expected it to be so weak.

but wont long this counter unless it make a substantial up n with volume to support it. 

yiming2000      ( Date: 16-May-2012 23:00) Posted: Are you buying in or kena trapped? rutheone1905      ( Date: 16-May-2012 22:09) Posted: a deeply suppressed counter takes some time to move up bcos along the way those kena trap will let go, so if u like to believe that the trend has changed for the better, then u got lots of time to buy in.

 

This counter no more meat! All the shortists run road lao....

Can see a long leg DOJI on the weekly chart now. Good entry price for long term investor.

 

Are you buying in or kena trapped?

rutheone1905      ( Date: 16-May-2012 22:09) Posted: a deeply suppressed counter takes some time to move up bcos along the way those kena trap will let go, so if u like to believe that the trend has changed for the better, then u got lots of time to buy in.

 

Infancybird - how heavily vested are you. How many lots and what price did you buy them at?

Despite SGX drop of 44 points, Biosensors still hanging in there at 1.215 with lots of buyers coming in.